National Institutes of Health (NIH)
Bethesda
MD
United States
45 articles with National Institutes of Health (NIH)
-
Longeveron Receives Prestigious NIH Small Business Innovation Research Grant
10/18/2018
Grant will be applied to Longeveron's Aging Frailty stem cell research
-
IDT Biologika Awarded 10-Year NIH Contract to Manufacture Vaccines and Biologics for Infectious Diseases
10/17/2018
The total funding could be up to $80 million over the course of the contract if all project milestones are met.
-
NIH Awards Grant to Battle Sepsis to San Diego's Allele Biotechnology and Pharmaceuticals
10/15/2018
The National Institute of General Medical Sciences, part of the National Institutes of Health, awarded Allele Biotechnology and Pharmaceuticals a Small Business Innovative Research grant to develop therapies for sepsis. -
Harvard Medical School and Brigham and Women’s Hospital are leading the call to remove the papers from the lab of Dr. Piero Anversa, a pioneer in the field of cardiac research.
-
St. Jude Children's Research Hospital researcher receives NIH high-risk, high reward award
10/11/2018
Dr. Charles Gawad recipient of NIH Director's New Innovator Award
-
Examples of new syndromes include hypotonia, ataxia, and delayed development syndrome (HADDS) and Sashi-Pena syndrome (SHAPNS).
-
Finding Therapeutic Targets to Prevent Atherosclerosis
10/9/2018
UH Biologist Discovers Protein Partnership That Protects Blood Vessels
-
Spinal Singularity Awarded Phase II SBIR Grant From NIH
10/4/2018
Spinal Singularity announced that the company was awarded a Phase II SBIR grant from the National Institute of Health (NIH)
-
Pain Therapeutics Announces $3.5 Million NIH Grant Award to Study Alzheimer’s Disease
10/4/2018
NIH Grant Will Enable Clinical Tests of PTI-125 in Patients with Alzheimer’s Disease
-
IBBR Receives $1.2M NIH Award to Develop 3D Modeling Tool That Could Lead to New Immunotherapies
10/3/2018
New computational tool supports the engineering and development of cancer immunotherapies by predicting how T cell receptors recognize and bind to their targets
-
Gamida Cell Ltd. filed for a $69 million initial public offering for the Nasdaq exchange, according to a filing submitted last week to the U.S. Securities and Exchange Commission, Israel’s Calcalist first reported last week.
-
Eli Lilly just signed a license deal with Tokyo’s Chugai Pharmaceutical Co. for OWL833, Chugai’s oral non-peptidic GLP-1 receptor agonist. It is Phase 1-ready being evaluated for type 2 diabetes.
-
Politicians might deny climate change, but disease-carrying insects and their pathogens aren’t—they’re exploiting it.
-
National Institutes of Health Names CHOP, Penn an Undiagnosed Diseases Network Site
9/24/2018
The National Institute of Health (NIH) has named Children's Hospital of Philadelphia and the Hospital of the University of Pennsylvania (HUP) as one of the newest sites of its Undiagnosed Diseases Network (UDN), awarding the two institutions $2.5 million in research grants.
-
The U.S. Food and Drug Administration is hoping to fill numerous vacancies at the regulatory agency. In June, the FDA laid out some of its hiring needs, as well as its approach to attracting top-quality talent in a report to Congress.
-
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
-
Debate Over the Orphan Drug Act Heats Up
8/30/2018
Recently, Milton Packer, a renowned cardiologist at Baylor Scott & White Health, wrote a criticism of the Orphan Drug Act and the resulting problems caused by the biopharma industry. John LaMattina, formerly president of Pfizer Global Research and Development and a current senior partner at PureT... -
Citing safety concerns, a watchdog organization is calling on the National institutes of Health to halt enrollment in a clinical trial evaluating a treatment for sepsis that the organization said is risky and flawed.
-
Companies Continue to Take Aim at Glioblastoma, a Cancer Highlighted by the Death of Sen. John Mc...
8/27/2018
McCain died Saturday after deciding to discontinue treatment for brain cancer. He approached the end of his life in the same manner in which he approached me that day in Raleigh – with the strength of character. -
The NIH’s National Institutes on Aging (NIA) and the Alzheimer’s Association brought together various experts and stakeholders to create the National Strategy for Recruitment and Participation in Alzheimer’s Disease Clinical Research.